Suchergebnisse

The governance of modern science requires a heightened sensitivity to societal issues in relation to, and in particular within, the life sciences. Current opinion about practices, potential achievements and applications of genomics research oscillates between hope and fear; promise and realization; intended and unintended consequences; knowledge and non-knowledge; understanding and misunderstanding - on all sides, including scientists. Governments, research funding agencies and industry seem to have learnt, to some extent, that what was once fittingly called "organized irresponsibility" (Beck, 1995) must be transformed into 'organized responsibility' if scientific research, new therapies and diagnostics, improved health care, and new consumer products and services are to stand any chance of being accepted by society.

Die von Thomas EBERLE mit seinem Band "Lebensweltanalyse und Handlungstheorie" vorgenommene methodologische Analysearbeit ist eine Art von "Reihentestung" gebräuchlicher Theorieangebote, in der er das alltägliche Handwerkszeug zur soziologischen Beschreibung von sozialer Praxis auf implizite und explizite Theorien des Verstehens dieser Praxis untersucht. Die diskutierten Handlungstheorien sind eine Auswahl von gebräuchlichen, empirisch ausgerichteten Ansätzen, welche in aufsatzförmigen Einzelanalysen, verteilt über mehrere Kapitel, unter die Lupe genommen werden. Als "Testkriterium" dient eine Zuspitzung der Prämissen zum subjektiven Sinnverstehen der Protosoziologie von Alfred SCHÜTZ: Wie viel Sinnadäquanz ermöglicht ein Ansatz jeweils? EBERLE geht der Fragestellung nach, ob und inwiefern die phänomenologische Lebensweltanalyse von Alfred SCHÜTZ geeignet ist, eine tragfähige wissenschaftstheoretische Grundlegung für die Soziologie und einige ihrer handlungstheoretischen Ansätze zu bieten. Interessiert an einem derartigen Unternehmen dürften im weitesten Sinne verstehend bzw. hermeneutisch arbeitende Forscherinnen sein, die sich prinzipiell des Problems bewusst sind, was es bedeutet, das Handeln und Verstehen sozialer Akteure verstehen zu wollen. Auch als Beitrag zur laufenden Debatte in FQS zu Qualitätsstandards qualitativer Sozialforschung kann EBERLEs Vorschlag diskutiert werden, obgleich zu berücksichtigen ist, dass es EBERLE wie SCHÜTZ weder um die Normativierung des Adäquanzpostulats oder um die Subjektivierung der Soziologie noch um Validität im wissenschaftlichen Relevanzsystem geht, sondern um die bestmöglichste sinnadäquate Annäherung an die Akteursperspektive.

Was ist darunter zu verstehen, wenn von einem Aufeinandertreffen der Kulturen die Rede ist? Was genau wird postuliert, wenn von »Kosmopolitisierung«, »Amalgamierung« oder »Hybridisierung« der Kulturen die Rede ist? Zur Beantwortung dieser und ähnlicher Fragestellungen wird hier das Phänomen der »kulturellen Differenz« ausgehend von empirischen Erkenntnissen grundlagentheoretisch reflektiert. Das Problem der kulturellen Differenz wird von der Konstitution des subjektiven Bewusstseins und den praktischen Problemen intersubjektiven Verstehens her aufgerollt. Vorgestellt werden materiale Analysen zur Herausbildung »kultureller Differenz«, deren Erkenntnisse sozialtheoretisch gedeutet werden können

'Innovations under pressure: Do cutting-edge research & medicine have a future?' This was the title of this year's press dinner organised by the research-based pharmaceutical company Roche on the occasion of the Capital City Congress 2024 - once again at the Austrian restaurant Ottersbach zu Berlin with probably the best veal cutlets west of Vienna. This time, the speakers were Prof Wolfgang Schütte, Medical Director, Clinic for Internal Medicine II - Pneumology at the Martha-Maria Halle-Dölau Hospital, who addressed the topic of 'Clinical research: Is Germany losing touch?', and Friedrich Fichtner, Access Lead Strategic Pricing & Reimbursement at Roche Pharma AG, who explained in his presentation why an AMNOG 2.0 is needed. Fichtner's presentation is the focus of this report.

Since its premiere a good six years ago, the Janssen Open House has continuously evolved: from an all-day live event in Neuss (before Corona) to an all-day livestream at the Janssen (during Corona) to the current curriculum: one or two closed virtual think tanks on one topic each, followed by a joint publication and a live-streamed panel discussion in which the discussion is 'opened' to the interested public. This year, the JOH took place live for the first time at the HSK in Berlin. The session was hosted by Dr Holger Bartz, Medical Director, and Dr Ursula Kleine-Voßbeck, Medical Director of Infectious Diseases and Vaccines at Johnson & Johnson Germany.

With a view to the upcoming state elections in Brandenburg on 22 September 2024, politicians discussed the challenges and opportunities for healthcare in the state as part of the 'AOK Forum live' talk format at the Old Town Hall in Potsdam, within sight of the Brandenburg state parliament. The title of the event: 'Brandenburg has the choice: For healthcare with a future'.

In seinem Report beschreibt MVF-Chrefredakteur Peter Stegmaier die Gemeinsamkeiten des Innovationsfondsprojekts "ProReVers" und der "Versorgungsbedarfsanalyse Brandenburg". Beide haben durchaus Bahnbrechendes vor.

Two presentations in particular gave rise to heated, sometimes very controversial, but therefore also interesting discussions during the MVF Congress 'The impact of the pandemic on healthcare'. The first was the statement by Prof Dieter Köhler, MD, former Medical Director of Kloster Grafschaft Hospital, that uncritical adherence to the S3 guideline 'Recommendations for inpatient treatment of patients with Covid-19' had led to an unnecessarily high number of corona deaths during the pandemic. The second was the presentation by Prof Dr Holger Pfaff, Head of the Institute for Medical Sociology, Health Services Research and Rehabilitation Science at the University of Cologne, who presented a new approach to how serious decisions can still be made on an uncertain data basis.

'This is about excess mortality and its measurement based on available data. It's about the effects of corona on inpatient care and the effect of forced ventilation in intensive care. And it is about evidence on collateral damage and the long-term effects of the decline in hospital cases for other diseases during corona.' With these words, MVF editor Prof Dr Reinhold Roski outlined the range of topics covered in the second part of the MVF Congress 'Pandemic impact on care'. Roski continued: 'We need a reappraisal and a learning process must begin - we want to contribute to this today, because healthcare research has a decisive contribution to make.'

The Health Atlas editions of the Scientific Institute of the AOK (WIdO), which have been published annually since 2019, make the health situation of all residents in Germany's 400 districts and cities transparent. The current edition of the Health Atlas, published at the end of 2023, focuses on the topic of back pain and its prevalence in the German population. The report also focuses on causes, consequences, prevention options and consequences for the healthcare system.